These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

786 related items for PubMed ID: 16243831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Bhattacharya-Chatterjee M.
    Cancer Res; 2003 Jun 01; 63(11):2844-54. PubMed ID: 12782590
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Sreedharan S, Mohanty K, Bhattacharya-Chatterjee M.
    Cancer Res; 2004 Jul 15; 64(14):4995-5003. PubMed ID: 15256474
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.
    Correale P, Del Vecchio MT, La Placa M, Montagnani F, Di Genova G, Savellini GG, Terrosi C, Mannucci S, Giorgi G, Francini G, Cusi MG.
    J Immunother; 2008 Jul 15; 31(2):132-47. PubMed ID: 18481383
    [Abstract] [Full Text] [Related]

  • 7. Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine.
    Wu Y, Wan T, Zhou X, Wang B, Yang F, Li N, Chen G, Dai S, Liu S, Zhang M, Cao X.
    Cancer Res; 2005 Jun 01; 65(11):4947-54. PubMed ID: 15930317
    [Abstract] [Full Text] [Related]

  • 8. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
    Cho JA, Lee YS, Kim SH, Ko JK, Kim CW.
    Cancer Lett; 2009 Mar 18; 275(2):256-65. PubMed ID: 19036499
    [Abstract] [Full Text] [Related]

  • 9. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.
    Tokunaga N, Murakami T, Endo Y, Nishizaki M, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2005 Feb 01; 11(3):1312-8. PubMed ID: 15709203
    [Abstract] [Full Text] [Related]

  • 10. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
    Huang Y, Fayad R, Smock A, Ullrich AM, Qiao L.
    Cancer Res; 2005 Aug 01; 65(15):6990-9. PubMed ID: 16061685
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice.
    Song S, Wang F, He X, He Y, Li D, Sun S.
    Vaccine; 2007 Jun 15; 25(25):4853-60. PubMed ID: 17418455
    [Abstract] [Full Text] [Related]

  • 12. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
    Huarte E, Sarobe P, Lu J, Casares N, Lasarte JJ, Dotor J, Ruiz M, Prieto J, Celis E, Borrás-Cuesta F.
    Clin Cancer Res; 2002 Jul 15; 8(7):2336-44. PubMed ID: 12114438
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
    Hao S, Bai O, Yuan J, Qureshi M, Xiang J.
    Cell Mol Immunol; 2006 Jun 15; 3(3):205-11. PubMed ID: 16893501
    [Abstract] [Full Text] [Related]

  • 14. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
    Conforti A, Peruzzi D, Giannetti P, Biondo A, Ciliberto G, La Monica N, Aurisicchio L.
    J Immunother; 2009 Sep 15; 32(7):744-54. PubMed ID: 19561534
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 16. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J.
    Cancer Res; 1997 Oct 15; 57(20):4570-7. PubMed ID: 9377571
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naitoh K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K, Yamagishi H.
    Int J Oncol; 2004 Apr 15; 24(4):909-17. PubMed ID: 15010829
    [Abstract] [Full Text] [Related]

  • 18. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.
    Hao X, Shao Y, Ren X, Liu H, Xu Q, Li H, Zhang P, An X, Ren B.
    J Cancer Res Clin Oncol; 2002 Sep 15; 128(9):507-15. PubMed ID: 12242516
    [Abstract] [Full Text] [Related]

  • 19. Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.
    Schmitz J, Reali E, Hodge JW, Patel A, Davis G, Schlom J, Greiner JW.
    Cancer Res; 2002 Sep 01; 62(17):5058-64. PubMed ID: 12208761
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST, Kim CH, Park MY, Won EH, Sohn HJ, Cho HI, Kang WK, Hong YK, Kim TG.
    Vaccine; 2006 Apr 05; 24(15):2860-8. PubMed ID: 16443309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.